Landsberg Bennett & Dubbaneh’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.82M Sell
7,918
-89
-1% -$22K 0.23% 106
2021
Q2
$1.84M Buy
8,007
+439
+6% +$88.2K 0.24% 104
2021
Q1
$1.4M Buy
7,568
+1,018
+16% +$199K 0.2% 108
2020
Q4
$1.11M Buy
+6,550
New +$978K 0.17% 108

Other funds holding LLY

Landsberg Bennett & Dubbaneh's LLY Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh reduced its Eli Lilly (LLY) stake by 1.1% in Q3 2021, selling an estimated $22K and leaving 7,918 shares worth $1.82M. The position accounts for 0.23% of the portfolio, ranked #106.

Landsberg Bennett & Dubbaneh first reported a position in LLY in Q4 2020 and has held it in 4 quarters since. The position peaked at $1.84M in Q2 2021. 2,051 funds tracked by Wall St. Rank hold LLY as of Q3 2021.

  • Landsberg Bennett & Dubbaneh held 7,918 shares of Eli Lilly worth $1.82M as of Q3 2021.
  • Landsberg Bennett & Dubbaneh sold 89 Eli Lilly shares in Q3 2021, an estimated $22K.
  • Eli Lilly made up 0.23% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #106 holding.
  • Landsberg Bennett & Dubbaneh first reported a position in Eli Lilly in Q4 2020 and has held it in 4 quarters since.
  • Landsberg Bennett & Dubbaneh's Eli Lilly position peaked at $1.84M in Q2 2021.
  • 2,051 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.